Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction
Abstract Inherited cardiomyopathies are common cardiac diseases worldwide, leading in the late stage to heart failure and death. The most promising treatments against these diseases are small molecules directly modulating the force produced by β-cardiac myosin, the molecular motor driving heart cont...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-06-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-47587-9 |